Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Tocilizumab in COVID-19 patients: a cohort study.
Vu CA, DeRonde KJ, Vega AD, Maxam M, Holt G, Natori Y, Zamora JG, Salazar V, Boatwright R, Morris SR, de Lima Corvino D, Betances AF, Colucci L, Keegan J, Lopez A, Rezk AH, Rodriguez Y, Moraru GM, Doblecki S, De La Zerda DJ, Abbo LM. Vu CA, et al. Among authors: deronde kj. BMC Infect Dis. 2020 Dec 22;20(1):964. doi: 10.1186/s12879-020-05701-4. BMC Infect Dis. 2020. PMID: 33353546 Free PMC article.
Development and Implementation of a COVID-19 Disease Response Protocol at a Large Academic Medical Center.
Maxam M, DeRonde KJ, Vega AD, Skiada D, Vu CA, Salazar V, Boatwright R, Cano-Casillas E, Goodnow V, Sposato KA, Paige PG, Zambrana D, Steigman DS, Memon AM, Abbo LM. Maxam M, et al. Among authors: deronde kj. Disaster Med Public Health Prep. 2020 Dec;14(6):792-795. doi: 10.1017/dmp.2020.166. Epub 2020 May 22. Disaster Med Public Health Prep. 2020. PMID: 32441232 Free PMC article.
Development of a Standardized Data Collection Tool for Evaluation and Management of Coronavirus Disease 2019.
Morris SR, Natori Y, Salguero D, Mantero A, Ma R, de Lima Corvino DF, Fernandez A, Lazo A, Vu CA, Bjork L, Serota D, Quevedo J, Vega A, Maxam M, DeRonde K, Barreiro P, Raccamarich P, Alvarez MR, Skiada D, Balan S, Ramanathan M, Holt G, Gonzales-Zamora J, Baracco GJ, Doblecki-Lewis S, Abbo LM, Lichtenberger PN, Alcaide ML. Morris SR, et al. Open Forum Infect Dis. 2020 Jul 29;7(9):ofaa320. doi: 10.1093/ofid/ofaa320. eCollection 2020 Sep. Open Forum Infect Dis. 2020. PMID: 32959015 Free PMC article.
Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa.
Alosaimy S, Lagnf AM, Morrisette T, Scipione MR, Zhao JJ, Jorgensen SCJ, Mynatt R, Carlson TJ, Jo J, Garey KW, Allen D, DeRonde K, Vega AD, Abbo LM, Venugopalan V, Athans V, Saw S, Claeys KC, Miller M, Molina KC, Veve M, Kufel WD, Amaya L, Yost C, Ortwine J, Davis SL, Rybak MJ. Alosaimy S, et al. Open Forum Infect Dis. 2021 Jul 14;8(8):ofab371. doi: 10.1093/ofid/ofab371. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34430671 Free PMC article.
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing.
Rojas LJ, Yasmin M, Benjamino J, Marshall SM, DeRonde KJ, Krishnan NP, Perez F, Colin AA, Cardenas M, Martinez O, Pérez-Cardona A, Rhoads DD, Jacobs MR, LiPuma JJ, Konstan MW, Vila AJ, Smania A, Mack AR, Scott JG, Adams MD, Abbo LM, Bonomo RA. Rojas LJ, et al. Among authors: deronde kj. PLoS One. 2022 Mar 31;17(3):e0265129. doi: 10.1371/journal.pone.0265129. eCollection 2022. PLoS One. 2022. PMID: 35358221 Free PMC article.
Impact of a real-time diagnostic and antimicrobial stewardship workflow on time to appropriate therapy for infections caused by multidrug-resistant Gram-negative organisms.
McCrink KA, DeRonde KJ, Jimenez A, Rosello G, Natori Y, Claeys KC, Martinez OV, De Pascale B, Perez-Cardona A, Abbo LM, Vega AD. McCrink KA, et al. Among authors: deronde kj. Int J Antimicrob Agents. 2023 Jun;61(6):106811. doi: 10.1016/j.ijantimicag.2023.106811. Epub 2023 Apr 8. Int J Antimicrob Agents. 2023. PMID: 37037319
12 results